Inhibrx

parachute chutes
Biotech

FDA rocked by leadership shake-ups—Chutes & Ladders

FDA rocked by leadership shake-ups. Sanofi snatches R&D head from GSK. Vida taps new managing directors.
Pac man eat MA deal buy sell merger

Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug

Jan 23, 2024 5:26am
Wall Street sign

Inhibrx pulls off $119M IPO on its 2nd go-around

Aug 20, 2020 10:21am
Nasdaq

Hoping to win where Novartis failed, Inhibrx files for $75M IPO

Jun 4, 2019 9:26am
Lots of nos

Five Prime cuts loose from InhibRx I-O deal

Aug 29, 2017 7:59am